Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05731986 · ClinicalTrials.gov registry record · NA
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
A NA study of Cardiovascular Diseases and Spinal Cord Injuries, sponsored by Kessler Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT05731986: Recruiting NA study of Cardiovascular Diseases and Spinal Cord Injuries, sponsored by Kessler Foundation.
NCT05731986 is a NA study of Cardiovascular Diseases and Spinal Cord Injuries that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 12 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05731986, a NA study of Cardiovascular Diseases and Spinal Cord Injuries, is actively recruiting participants, sponsored by Kessler Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the effect of transcutaneous spinal cord stimulation on blood pressure in individuals with an acute spinal cord injury (within 30 days of injury). Blood pressure instability, specifically orthostatic hypotension (a drop in blood pressure when moving lying flat on your back to an upright position), appears early after the injury and often significantly interferes with participation in the critical rehabilitation time period. The main questions it aims to answer are: 1. Can optimal spinal stimulation increase blood pressure and resolve orthostatic symptoms (such as dizziness and nausea) when individuals undergo an orthostatic provocation (a sit-up test)? Optimal stimulation and sham stimulation (which is similar to a placebo treatment) will be compared. 2. What are the various spinal sites and stimulation parameters that can be used to increase and stabilize blood pressure to the normal range of 110-120 mmHg? Participants will undergo orthostatic tests (lying on a bed that starts out flat and then moved into an upright seated position by raising the head of bed by 90° and dropping the base of the bed by 90° from the knee) with optimal and sham stimulation, and their blood pressure measurements will be evaluated and compared.
Primary Outcome
Identify scTS spinal segments that restore systolic BP within the normotensive range (110-120 mmHg).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Orthostatic challenge
- DEVICE Biostim-5 transcutaneous spinal stimulation - Mapping
- DEVICE Biostim-5 transcutaneous spinal stimulation - "Optimal" testing
- DEVICE Biostim-5 transcutaneous spinal stimulation - "Sham" testing
Study Locations (1)
New Jersey
- Kessler Foundation - West Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT05731986 shows while recruiting
NCT05731986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 10 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 4 interventions - of which Orthostatic challenge is the first listed.
NCT05731986 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05731986 about?
NCT05731986 is a clinical study titled "Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)". The goal of this clinical trial is to evaluate the effect of transcutaneous spinal cord stimulation on blood pressure in individuals with an acute spinal cord injury (within 30 days of injury). Blood pressure instability, specifically orthostatic hypotension (a drop in blood pressure when moving lyi...
What is the current status of trial NCT05731986?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2023-12-01. Estimated completion is 2026-08.
What conditions does trial NCT05731986 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Spinal Cord Injuries, Blood Pressure, Nervous System Diseases, Orthostatic Hypotension.
What interventions are being tested in trial NCT05731986?
The interventions under investigation include: Orthostatic challenge (DIAGNOSTIC_TEST), Biostim-5 transcutaneous spinal stimulation - Mapping (DEVICE), Biostim-5 transcutaneous spinal stimulation - "Optimal" testing (DEVICE), Biostim-5 transcutaneous spinal stimulation - "Sham" testing (DEVICE).
Who is sponsoring clinical trial NCT05731986?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05731986 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05731986's enrollment target sits among peer trials
12 292nd of 300 higher than 8 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI